Latest News for: lexicon

Edit

Statement of Changes in Beneficial Ownership (Form 4) (Lexicon Pharmaceuticals Inc)

Public Technologies 23 Feb 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSION ... 2 ... LEXICON PHARMACEUTICALS, INC ... Lexicon Pharmaceuticals Inc.
Edit

Notice of Sales of Unregistered Securities (Form D) (Lexicon Pharmaceuticals Inc)

Public Technologies 17 Feb 2026
) ... 20549 ... 0001062822 LEXICON PHARMACEUTICALS, INC./DE. LEXICON GENETICS INC/TX. Lexicon Genetics Inc./TX. LEXICON PHARMACEUTICALS, INC./DE ... LEXICON PHARMACEUTICALS, INC ... LEXICON PHARMACEUTICALS, INC ... Lexicon Pharmaceuticals, Inc ... Lexicon Pharmaceuticals Inc.
Edit

Preliminary Proxy Statement (Form PRE 14A) (Lexicon Pharmaceuticals Inc)

Public Technologies 17 Feb 2026
LEXICON PHARMACEUTICALS, INC ... I am pleased to invite you to attend the 2026 annual meeting of stockholders of Lexicon Pharmaceuticals, Inc ... Thank you for your ongoing support of and continued interest in Lexicon Pharmaceuticals.
Edit

The lexicon of love: How Gen Z rewrote romance and brands came to listen

Indian Express 13 Feb 2026
.
Edit

Initial Statement of Beneficial Ownership (Form 3) (Lexicon Pharmaceuticals Inc)

Public Technologies 13 Feb 2026
) FORM 3. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C ... OMB Number. 3235-0104. Estimated average burden hours per response... 0.5. (Print or Type Responses) 1 ... 2 ... 02/02/2026 3 ... LEXICON PHARMACEUTICALS, INC ... 5 ... 5) ... Lexicon Pharmaceuticals Inc.
Edit

The prepper’s lexicon: Why knowing the lingo is a key survival skill

Natural News 08 Feb 2026
Terms like "bugging in" (staying home) and "bugging out" (evacuating), along with gear like a BOB (bug-out bag), turn abstract preparedness into s... .
Edit

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

Nasdaq Globe Newswire 06 Feb 2026
06, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc ... LXRX) (“Lexicon”) today announced the closing of its previously announced ...
Edit

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private

Hastings Tribune 06 Feb 2026
06, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc.
Edit

Free Writing Prospectus (Form FWP) (Lexicon Pharmaceuticals Inc)

Public Technologies 06 Feb 2026
LEXICON ANNOUNCES CLOSING OF APPROXIMATELY $94.6 MILLION PUBLIC ... The Woodlands, Texas, February 6, 2026 - Lexicon Pharmaceuticals, Inc ... About Lexicon Pharmaceuticals ... Lexicon Pharmaceuticals, Inc ... Lexicon Pharmaceuticals Inc.
Edit

LEXICON ANNOUNCES PRICING OF APPROXIMATELY $94.6 MILLION PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT (Form 8-K) (Lexicon Pharmaceuticals Inc)

Public Technologies 02 Feb 2026
LEXICON ANNOUNCES PRICING OF APPROXIMATELY $94.6 MILLION PUBLIC ... The Woodlands, Texas, January 29, 2026 - Lexicon Pharmaceuticals, Inc ... All of the shares are being offered by Lexicon ... Lexicon Pharmaceuticals Inc.
Edit

Supplemental Prospectus (Form 424B5) (Lexicon Pharmaceuticals Inc)

Public Technologies 02 Feb 2026
Lexicon Pharmaceuticals, Inc ... Proceeds to Lexicon Pharmaceuticals, Inc ... In this prospectus, "Lexicon," "Lexicon Pharmaceuticals," "we," "us" and "our" refer to Lexicon Pharmaceuticals, Inc.
Edit

Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private

Hastings Tribune 30 Jan 2026
30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc.
Edit

Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

Nasdaq Globe Newswire 30 Jan 2026
30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc ... LXRX) (“Lexicon”) today announced the pricing of its previously announced underwritten public offering of 32,000,000 shares of its common stock, par value $0.001.
Edit

LEXICON ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK (Form 8-K) (Lexicon Pharmaceuticals Inc)

Public Technologies 29 Jan 2026
LEXICON ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK. The Woodlands, Texas, January 29, 2026 - Lexicon Pharmaceuticals, Inc ... In addition, Lexicon intends to grant the underwriters a 30-day option to purchase additional shares of common stock.
Edit

Lexicon Announces Proposed Public Offering of Common Stock

Hastings Tribune 29 Jan 2026
29, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc.

Article Search

tools
×
×
×
×